Sign in

CIK 0000014272

  • Large accelerated filer

BRISTOL MYERS SQUIBB CO

Sign in to watch
Ticker
BMY
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
220790350
Phone
+1 609-252-4621
Business address
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543

Securities

  • BMY Bristol-Myers Squibb Company Common Stock NYSE
  • CELG-RI Rights NYSE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$677,826
in 3 filings

Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-03-10 VESSEY RUPERT EVP, Research & Early Dev. Option exercise · Market Share Units −7,423 14,848
2022-03-10 VESSEY RUPERT EVP, Research & Early Dev. Option exercise · Market Share Units −7,824 23,475
2022-03-10 VESSEY RUPERT EVP, Research & Early Dev. Grant or award · Market Share Units +28,589 28,589
2022-03-10 VESSEY RUPERT EVP, Research & Early Dev. Grant or award · Performance Shares +42,884 42,884
2022-03-10 Mily Elizabeth EVP, Strategy & BD Option exercise +4,005 8,246
2022-03-10 Mily Elizabeth EVP, Strategy & BD Other acquisition +449 8,695
2022-03-10 Mily Elizabeth EVP, Strategy & BD Shares withheld for taxes −1,875 $68.42 $128K 6,820
2022-03-10 Mily Elizabeth EVP, Strategy & BD Option exercise · Market Share Units −4,005 12,017
2022-03-10 Mily Elizabeth EVP, Strategy & BD Grant or award · Market Share Units +14,634 14,634
2022-03-10 Mily Elizabeth EVP, Strategy & BD Grant or award · Performance Shares +21,952 21,952
2022-03-01 VESSEY RUPERT EVP, Research & Early Dev. Option exercise +23,350 79,587
2022-03-01 VESSEY RUPERT EVP, Research & Early Dev. Shares withheld for taxes −10,303 $68.63 $707K 69,284
2022-03-01 VESSEY RUPERT EVP, Research & Early Dev. Option exercise · Restricted Stock Units −23,350 0
2022-03-01 Elkins David V EVP, Chief Financial Officer Option exercise +24,577 132,034
2022-03-01 Elkins David V EVP, Chief Financial Officer Shares withheld for taxes −10,381 $68.63 $712K 121,653
2022-03-01 Elkins David V EVP, Chief Financial Officer Option exercise · Restricted Stock Units −24,577 0
2022-02-24 Caforio Giovanni Board Chair and CEO Sale −30,000 $67.00 $2.0M 453,455.33
2022-02-04 VESSEY RUPERT EVP, Research & Early Dev. Option exercise +3,593 57,549
2022-02-04 VESSEY RUPERT EVP, Research & Early Dev. Shares withheld for taxes −1,312 $64.99 $85K 56,237
2022-02-04 VESSEY RUPERT EVP, Research & Early Dev. Option exercise · Restricted Stock Units −3,593 0

Page 65 of 73 · 1,445 trades